Experiments conducted in the syngeneic mouse tumor model showed that anti-TGF-β1 treatment suppressed the enhancement of MC38-tumor growth promoted by Atp6v0a1 overexpression (Fig. 4J–L). Here, TGFB1 is linked to neoplasm.